Navigantis
Miami-based neurovascular surgical robotics startup developing the VASCO robotic platform for interventional stroke care and cerebral angiography.
Navigantis is a medical robotics company founded in 2022 and headquartered in Miami, Florida, USA, with a presence in Seoul, South Korea. The company was co-founded by Hyosig Kang and Mor Dayan. Navigantis developed the VASCO robotic platform, an interventional robotic system designed for a wide range of neurovascular procedures including diagnostic cerebral angiography, brain tumor embolization, and mechanical thrombectomy for acute ischemic stroke.
The VASCO platform aims to enable physicians to perform neurovascular interventions regardless of patient location, supporting potential telesurgery applications. In July 2024, Navigantis closed a $12 million Series A financing round led by Puma Venture Capital with participation from Cormorant Asset Management and Mirae Asset Capital. The company subsequently completed first-in-human clinical cases with the VASCO platform in a neurovascular study, treating patients with diagnostic cerebral angiogram and brain tumor embolization.
Primary type & automation activities this supplier delivers:
VASCO Robotic Platform
Interventional robotic platform for neurovascular procedures including stroke thrombectomy, cerebral angiography, and brain tumor embolization.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
-
8
How Yuanhua Robotics’ 5,000 Surgeries Are Redefining Trust in China’s AI Surgical Robots RobotToday · Oct 16, 2025
- 9
- 10
-
11
Suzy Teele’s Mission at ARM Institute RobotToday · Oct 13, 2026
- 12
- 13
- 14
-
15
Beyond the Gantt Chart: How Skody AI Explains Why Orders Are Late RobotToday · Jun 22, 2026
Contact Navigantis
WEBSITE
https://navigantis.coHEADQUARTERS
United States
Company Facts
Founded
2022
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
